Close Menu

hepatitis

The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.

Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.

In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.

It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.

In PNAS this week: decreased DOCK4 expression in myelodysplastic syndromes plus anemia, hepatitis A evolution, and more.

A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.

Following a beta evaluation of the system, a virology lab in Sheffield, UK, ran a workflow assessment and found improvements with the system.

The hepatitis C virus test has been approved for both the confirmation of active infection as well as for viral load monitoring.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.